Form 8-K - Current report:
SEC Accession No. 0001493152-24-048687
Filing Date
2024-12-04
Accepted
2024-12-04 16:57:34
Documents
18
Period of Report
2024-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45219
2 ex10-1.htm EX-10.1 293517
3 ex99-1.htm EX-99.1 14226
4 ex99-2.htm EX-99.2 12259
5 ex99-1_001.jpg GRAPHIC 5922
6 ex99-2_001.jpg GRAPHIC 29618
  Complete submission text file 0001493152-24-048687.txt   663724

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE juns-20241202.xsd EX-101.SCH 3051
8 XBRL LABEL FILE juns-20241202_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE juns-20241202_pre.xml EX-101.PRE 24189
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3779
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41265 | Film No.: 241526882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)